Introduction
drops of saturated picric acid for 1 min respectively. Finally, sections were immersed twice in 158 xylene (5 min each) and mounted with DPX. Images were captured using MIRAX MIDI slide 159 scanner microscope (Carl Zeiss) with a 10x objective and MIRAX Scan software.
161

Immunohistochemistry
162
Cryosections were fixed in 100% acetone at -20 ºC for 5 min and then rinsed with 1x 163 PBS for 5 min. Antigen retrieval was performed only for Ki67 immunostaining. For antigen 164 retrieval, sections were immersed in 95-100 ºC citrate buffer (pH 6.0) for 10 min and then 165 cooled for 30 min. Next, sections were blocked with their respective blocking buffer for a 166 specific incubation time in a humid chamber. Sections were then incubated with the respective 167 primary and secondary antibodies as described above, with the exception of Mstn, which was 168 detected using a streptavidin-conjugated tertiary antibody. Finally, sections were mounted with 169 DAPI-containing mounting media (Vector Laboratories). 
Isolation and Culture of Primary Mouse Keratinocyte
176
Primary mouse epidermal keratinocytes were isolated from neonates (0-2 days old) 177 according to previously described protocols, with slight modifications (30). Briefly, pups were 178 decapitated with limbs and tail removed. A ventral cut was made from neck to tail and the whole 179 skin was peeled off. Each skin was then submerged in 3 ml of cold dispase solution (0.5 U/ml) overnight at 4 °C. Epidermis and dermis were separated the next day with fine forceps.
181
Epidermis extracted from 5-8 pups were pooled and transferred to a 50-ml tube containing 10 182 ml of low-calcium (0.06 mM) and SFM keratinocyte medium (Invitrogen), supplemented with 183 recombinant epidermal growth factor (0.4 ng/ml) and bovine pituitary extract (40 μg/ml).
184
Epidermal keratinocytes were mechanically separated by vigorous shaking for 20 seconds. Cell 185 clumps were then removed by passing the cell suspension through a 100-μm cell strainer.
186
Cultures were maintained in a 5% CO 2 humidified incubator at 37°C. Medium was changed 187 every 2 days and cells were subcultured upon reaching 70% confluence. For subculture, medium The scratch-wound assay was performed as previously described (13) . Briefly, when 197 primary cultured keratinocytes reached confluence, a pipette tip was used to scratch a line 198 followed by washing with PBS to remove scratched cells. Mitomycin C was added at a 199 concentration of 2 µg/ml to inhibit cell proliferation prior to image capture at 5-min intervals 200 over a total period of 12 h using a Carl Zeiss live imaging microscope. fixed with 1% glutaraldehyde for 15 min followed by incubation with 0.05% crystal violet for 10 214 min at room temperature. After staining, excess dye was removed and the cells were then 215 washed three times with 1 × PBS. The plate was subsequently dried at room temperature 216 overnight, after which, 50 μl of 1% triton-X/PBS was added to each well to solubalize the dye.
217
The absorbance of the crystal violet was read at OD 590nm .
218
219
RNA Extraction and Quantitative Real-time PCR (qPCR)
220
Total RNA was extracted from the skin wound biopsy using TRIzol reagent, as per the 221 manufacturer's instructions (Invitrogen). RNA was further purified using the RNeasy mini kit 222 (Qiagen), prior to cDNA synthesis using the Superscript II First strand synthesis system
Immunobloting (Western Blot)
228
Skin wound biopsies were homogenized in protein lysis buffer containing 50 mM 229 Na 2 H 2 PO 4 , 250 mM NaCl, 1% Triton X-100, and 0.1% SDS. This was followed by 230 centrifugation at 12,000 × g for 15 min. The supernatant was collected and 10 µg of the 231 extracted proteins were resolved by 4-12% NuPAGE (Invitrogen) followed by transfer onto a 232 nitrocellulose membrane. Membranes were blocked with polyvinylpyrrolidone (PVP) blocker 233 (1% PVP, 1% polyethylene glycol, and 0.3% bovine serum albumin in TBST) for 1 h.
234
Membranes were incubated with primary and secondary antibodies in the PVP blocking solution 235 overnight and for 1 h, respectively. Immunoreactivity was detected through enhanced 236 chemiluminescence.
238
Statistical Analysis
239
The Mann-Whitney test was used for statistical analysis of cell migration and the 240 adhesion assay. Two-tailed Student's t-test was used for all other statistical significance 241 determinations. P < 0.05 was considered statistically significant. Error bars represent ± SEM.
Results
245
Expression of Mstn is Restricted to the Epidermis, Dermis and Hair Follicles in Skin
246
As a first step towards understanding the role of Mstn in skin wound healing, we 247 determined the expression of Mstn in skin. Our qPCR results showed that Mstn was expressed 248 in skin, and that the expression level was relatively lower than in muscle ( Figure 1A ).
249
Immunohistochemical analysis in mouse ( Figure 1C ) and human skin ( Figure 1D ) showed that 
Delayed Wound Healing in Mstn-Null Mice
257
A significant difference in wound healing rate was observed between wild-type and
258
Mstn-null mice (Figure 2A ). Following full-thickness excisional wounding, the rate of wound 259 healing was delayed in Mstn-null mice when compared to the wild-type mice as indicated by the 260 wound area ( Figure 2B ). In particular, the wound area of Mstn-null mice was 1. 78-, 5.56-, 23.39-261 and 5.13-fold larger than that of the wild-type mice at post-wounding days 3, 5, 7 and 10 262 respectively (P < 0.05). An approximate delay of 8 days in complete wound closure was 263 observed in the Mstn-null mice as compared to the wild-type mice, with similar wound healing 264 observed between Mstn-null mice on day 15 and wild-type controls on day 7 post-wounding. 
Wound Contraction
268
To determine the reasons for delayed wound healing in Mstn-null mice, we performed 269 histomorphometric analysis on the wounded skin biopsies at various time points ( Figure 3A) μm respectively, P < 0.01) ( Figure 3D ). Taken together, these data suggest that there is delayed 286 re-epithelialization in Mstn-null mice during skin wound regeneration. Next we assessed the 287 extent of dermal wound contraction, as quantified by the distance between peri-wound hair peri-wound hair follicles in Mstn-null mice (wild-type versus Mstn-null: 1266.76 ± 26.59 μm 290 versus 1560.57 ± 7.03 μm, P < 0.01) at day 10 post-wounding ( Figure 3E ), which is indicative of 291 reduced dermal wound contraction. In summary, we conclude that the slower wound healing 292 observed in Mstn-null mice is a result of delayed re-epithelialization and wound contraction. proliferation in vitro, we assessed the proliferation rate of primary keratinocytes extracted from wild-type and Mstn-null mice through BrdU staining and FACS analysis and also assessed the
Delayed Migration and Impaired Cell Adhesion in Keratinocytes Isolated from Mstn-Null
324
Mice
325
To analyze keratinocyte migration in further detail, we performed an in vitro scratch-326 wound assay (13) which mimics the in vivo keratinocyte migration during wound healing. As 327 shown in Figure 5C , a significant delay in keratinocyte migration can be seen in Mstn-null 328 cultures when compared to wild-type counterparts. Next we quantified the extent of keratinocyte 7A, myofibroblasts were readily detected in the skin wound area of wild-type mice, as indicated 375 by the intense α-SMA staining. However, in contrast, the level of α-SMA staining in the skin 376 wound of Mstn-null mice was greatly reduced ( Figure 7A ).
377
In addition to analyzing α-SMA expression histologically, we next analysed the protein 378 levels of α-SMA via western blot. As shown in Figure 7B , reduced α-SMA protein expression To further analyze the involvement of TGF-β signaling in Mstn-null mice skin wound healing, 391 either recombinant TGF-β1 protein or vehicle control were topically applied onto the skin 392 wound area immediately upon excisional wounding. As can be seen in Figure 8A , a significant 393 difference in wound healing was observed between vehicle and TGF-β1 treated Mstn-null mice,
394
with topical application of TGF-β1 leading to accelerated skin wound healing in Mstn-null mice.
395
To determine the cause of the accelerated skin wound healing, histomorphometric analysis was 396 performed on the wounded skin biopsies at various time points ( Figure 8B ). During wound 397 healing, the recovery rate is primarily determined by re-epithelialization and the contractile 398 action of myofibroblasts, therefore, we analyzed the thickness of the epidermis and the distance 399 between the peri-wound hair follicles as parameters for assessing skin wound healing. On day 10 400 post-wounding, we observed that in Mstn-null mice treated with TGF-β1, the wounded 401 epidermis was significantly thinner, when compared to vehicle treated Mstn-null mice (Vehicle 402 versus TGF-β1: 920.53±38.33 μm versus 381.25±16.42 μm respectively, P < 0.001) ( Figure 8C ).
403
In addition, a significant reduction in the distance between peri-wound hair follicles was 
421
We demonstrated that decreased re-epithelialization in Mstn-null mice was due to a healing in a previous publication (45). In addition, Mstn-null primary keratinocytes also exhibit 434 a reduced migration rate during the initial stages of wound healing, which we suggest is due to reduced TGF-β signaling. In agreement with our hypothesis, topical addition of exogenous TGF-on TGF-β1 signaling has been previously reported in human heart, where decorin is involved in Myofibroblasts have been shown to have two main functions during wound healing.
471
Firstly, myofibroblasts exert contractile strength and align collagen via integrins to contract 472 wound edges (11, 14, 16) , and secondly, deposit ECM collagen fibers to strengthen the wound 473 (19, 48), thus, myofibroblast activation and differentiation is a crucial step in wound contraction.
474
As shown in the present manuscript we found reduced myofibroblasts, as assessed through α-
475
SMA expression, in Mstn-null mice when compared to wild-type mice during skin wound 476 healing. TGF-β has been shown to be a critical factor in myofibroblast activation via its 477 stimulatory action on fibroblast proliferation, myofibroblast differentiation, and matrix 478 deposition (8, 33). Therefore, reduced TGF-β signaling may be responsible for the diminished 479 myofibroblast differentiation and delayed dermal wound contraction observed in Mstn-null 480 mice. To date, however, the mechanism by which TGF-β1 regulates myofibroblast activation and differentiation remains unclear. Nonetheless, it has been proposed that TGF-β1 regulates 482 these events in myofibroblasts via cell adhesion-dependent integrin signaling-mediated Reduced migration rate and Protracted Keratinocyte proliferation and collagen deposition
